About Harry Robb
Harry Robb is a board member at Remedium Bio.
Experience
This experience comes from Harry Robb's profile and from SEC filings. For roles taken from filings, the years are when the filings name Harry Robb in the role, so the role may have started earlier or lasted longer.
Remedium Bio Inc. Current
Board Member
2026 – Present · Needham, MA
Develops gene therapies for people with chronic diseases.
PR
PriveBio Current
Board Member
2026 – Present
BI
BIOIO Current
Board Member
2025 – Present
TA
TECregen AG Current
Board Member
2025 – Present
DL
Diligenix Solutions Limited Current
Director
2024 – Present
MB
Matter Bio Current
Board Observer
2024 – Present
BT
Bolden Therapeutics Current
Board Observer
2024 – Present
LV
Lifespan Vision Ventures Current
Principal
2023 – Present
LT
Lift Therapeutics Current
Board Observer
2023 – Present
LT
Longevity.Technology
Deal Origination & Capital Raising Manager
2021 – 2023
FV
FLYFWD Ventures
Research Analyst
2020 – 2021
OX
OXWASH
Business Development Intern
2020 – 2021
AG
Azalee Group
Healthcare Intern
2019
Key Colleagues at Startups
The people Harry Robb works with at each company, as listed on that company's latest Form D.
Remedium Bio Inc. · Form D, May 18, 2026
Alexei Goraltchouk
Chief Technology Officer and director
Frank Luppino
President and CEO, director
Richard Hague
Board Member